Tigan and Atrovent drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tigan (trimethobenzamide hydrochloride) and Atrovent (ipratropium bromide). Common drug interactions include drug hypersensitivity among females and disorientation among males.

The phase IV clinical study analyzes what interactions people have when they take Tigan and Atrovent. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Tigan?

Tigan has active ingredients of trimethobenzamide hydrochloride. It is often used in nausea. eHealthMe is studying from 1,904 Tigan users. Check the latest studies of Tigan.

What is Atrovent?

Atrovent has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 33,210 Atrovent users. Check the latest studies of Atrovent.

On Jul, 18, 2026

17 people who take Tigan and Atrovent together, and have interactions are studied.

What are the common drug interactions of Tigan and Atrovent, by gender? *:

female:

Drug hypersensitivity
Anorectal discomfort
Atelectasis (partial or complete collapse of the lung)
Chills (felling of cold)
Chronic kidney disease
Dyskinesia (abnormality or impairment of voluntary movement)
Dyspnoea (difficult or laboured respiration)
Failure to thrive (inadequate weight gain and physical growth in children)
Fatigue (feeling of tiredness)
Hepatitis cholestatic (flow of bile from the liver is slowed or blocked)

male:

Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Pancreatitis (inflammation of pancreas)
Fatigue (feeling of tiredness)
Flatulence (flatus expelled through the anus)
Gait disturbance
Hypertension (high blood pressure)
Hypokalaemia (low potassium)
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
Hypotension (abnormally low blood pressure)
Oedema peripheral (superficial swelling)

What are the common drug interactions of Tigan and Atrovent, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Pancreatitis (inflammation of pancreas)
Drug hypersensitivity
Atelectasis (partial or complete collapse of the lung)
Overdose
Pneumonia mycoplasmal (mycoplasma pneumonia (mp) is a contagious respiratory infection)
Pseudarthrosis (bones that do not heal after fracture)
Respiratory failure (inadequate gas exchange by the respiratory system)
Spinal osteoarthritis (joint cartilage loss in spine)

50-59:

Failure to thrive (inadequate weight gain and physical growth in children)
Hepatitis cholestatic (flow of bile from the liver is slowed or blocked)
Liver injury

60+:

Fatigue (feeling of tiredness)
Arthralgia (joint pain)
Gait disturbance
Hypertension (high blood pressure)
Hypokalaemia (low potassium)
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
Hypotension (abnormally low blood pressure)
Oedema peripheral (superficial swelling)
Pain
Pain in extremity

What are the existing conditions these people have? *

Pain: 4 people, 23.53%
Type 2 Diabetes: 3 people, 17.65%
Stress And Anxiety: 3 people, 17.65%
Asthma: 3 people, 17.65%
Parkinson's Disease: 3 people, 17.65%
Back Pain: 3 people, 17.65%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 17.65%
High Blood Cholesterol: 3 people, 17.65%
Breakthrough Pain: 2 people, 11.76%
Constipation: 2 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take Tigan and Atrovent?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously